Signature Wealth Management Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
1,024
+5
+0.5% +$5.11K 0.57% 36
2026
Q1
$937K Sell
1,019
-24
-2% -$24.3K 0.47% 39
2025
Q4
$1.12M Buy
1,043
+4
+0.4% +$3.83K 0.55% 37
2025
Q3
$793K Buy
1,039
+61
+6% +$45.4K 0.42% 48
2025
Q2
$763K Buy
978
+197
+25% +$153K 0.44% 45
2025
Q1
$645K Buy
781
+270
+53% +$225K 0.42% 45
2024
Q4
$395K Buy
511
+100
+24% +$82.8K 0.27% 67
2024
Q3
$364K Buy
411
+123
+43% +$111K 0.26% 70
2024
Q2
$261K Buy
+288
New +$230K 0.2% 85

Other funds holding LLY

Signature Wealth Management Partners's LLY Position: Q2 2026 in Review

Signature Wealth Management Partners increased its Eli Lilly (LLY) stake by 0.49% in Q2 2026, buying an estimated $5.11K and bringing the position to 1,024 shares worth $1.23M. The position accounts for 0.57% of the portfolio, ranked #36.

Signature Wealth Management Partners first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signature Wealth Management Partners held 1,024 shares of Eli Lilly worth $1.23M as of Q2 2026.
  • Signature Wealth Management Partners bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.57% of Signature Wealth Management Partners's portfolio in Q2 2026, its #36 holding.
  • Signature Wealth Management Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signature Wealth Management Partners's 13F filing for Q2 2026, filed 29 Jul 2026.